简述摘要
Location: China, Guangdong Province, Shenzhen
Employees: 201-500
Investors 1
| Date | Name | Website |
| 11.02.2021 | Cathay Cap... | cathaycapi... |
Mentions in press and media 8
| Date | Title | Description |
| 15.10.2024 | Fapon showcases its total IVD solutions at Hospital Expo to empower local Indonesian IVD industry | DONGGUAN, China, Oct. 15, 2024 /PRNewswire/ -- Fapon, a global leading life sciences company, is excited to participate in the Hospital Expo in Jakarta, Indonesia, from October 16 – 19. Fapon will showcase its total IVD solutions, including... |
| 18.08.2024 | Fapon Biotech Delivers Antigen Diagnostic Solutions to Help Control Monkeypox Outbreak in Africa | SHENZHEN, China, Aug. 18, 2024 /PRNewswire/ -- Fapon Biotech is a global leader in the In-vitro Diagnostics (IVD) industry, with a steadfast commitment to advancing global health by providing innovative diagnostic solutions. As the World He... |
| 01.08.2024 | The Director General of Pharmaceuticals and Medical Devices Visits Fapon in Indonesia | JAKARTA, Indonesia, Aug. 1, 2024 /PRNewswire/ -- The Ministry of Health of the Republic of Indonesia, represented by the Director General of Pharmaceuticals and Medical Devices (Dirjen Falmakes), Dr. Dra. Lucia Rizka Andalucia, along with t... |
| 04.06.2024 | Fapon Biopharma Announces a Safer Immunotherapy for Cancers | SAN DIEGO, June 4, 2024 /PRNewswire/ -- At Bio International Convention 2024, which is taking place here in San Diego during June 3-6, Fapon Biopharma, an innovator in developing therapeutic antibodies and fusion proteins, has announced an ... |
| 27.04.2023 | Fapon Biotech Announces Chemiluminescence One-Stop Solution Strategy in India at Medical Fair India 2023 | NEW DELHI, April 27, 2023 /PRNewswire/ -- Fapon Biotech Inc. (Fapon Biotech, or the Company), a global leading IVD enterprise, has announced its innovative chemiluminescence one-stop solution strategy at the 28th edition of Medical Fair Ind... |
| 22.02.2023 | Fapon Biopharma's Anti-CD47 Antibody FP002 Earns IND Approval from FDA | SHENZHEN, China, Feb. 22, 2023 /PRNewswire/ -- Fapon Biopharma, an innovative biotech company, announced today that its Investigational New Drug (IND) application of FP002, an anti-CD47 monoclonal antibody drug candidate, has been approved ... |
| 22.02.2023 | Fapon Biopharma's Anti-CD47 Antibody FP002 Earns IND Approval from FDA | SHENZHEN, China, Feb. 22, 2023 /PRNewswire/ -- Fapon Biopharma, an innovative biotech company, announced today that its Investigational New Drug (IND) application of FP002, an anti-CD47 monoclonal antibody drug candidate, has been approved ... |
| 10.01.2023 | FAPON to attend 41st Annual J.P. Morgan Healthcare Conference | SHENZHEN, China, Jan. 10, 2023 /PRNewswire/ -- FAPON, a leading life sciences company, today announces that its senior executive management will attend the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, CA. Jielun ZHU, CFO ... |